30 abril 2015
A clinical trial for patients with degenerative eye diseases is the first to test the safety of an embryonic stem cell therapy for people of Asian descent. The study, which followed four individuals for a year after they were treated with embryonic stem cell-derived retinal pigment epithelial cells for macular degeneration, observed no serious side effects (tumor growth or other unexpected effects) related to the therapy.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/L_1p5SMjL9g/150430124116.htm
